HbA1c versus blood sugar: why can the numbers tell different stories?
What is the difference between an average over months and a glucose reading today?
On this page
A1c is a measure of glycated haemoglobin used to assess longer-term glucose exposure. A glucose test measures glucose in a specimen at a particular time. Their numbers should not be compared as though they were the same test.[8]
What does this actually mean?
The meaning
HbA1c, also called A1C or glycated haemoglobin, measures haemoglobin with glucose attached. Because red blood cells circulate for weeks to months, it reflects longer-term glucose exposure rather than the sugar concentration in one sample at one moment. A fasting or random blood-glucose measurement and an A1c result therefore answer different questions.[1]
A familiar example
A glucose reading after breakfast and an A1c result from the same appointment can look different without either automatically being wrong. One captures a particular time; the other reflects preceding weeks. A1c is also weighted toward more recent glucose exposure, rather than giving every day in the last three months exactly equal importance.[5]
What the units mean
A1c may be reported as a percentage in the NGSP system or in mmol/mol using the IFCC system. These are two ways of reporting glycated haemoglobin. Neither is the same measurement as glucose in mg/dL or mmol/L. The similar-looking abbreviations do not make the numbers directly interchangeable.[4]
What it does not tell you
A1c does not show when glucose was high or low during a day. An estimated average glucose printed alongside it is calculated from a study relationship, not a second direct glucose measurement. The ADAG study established that relationship in 507 people, with variation around the estimate; an individual’s exact daily pattern cannot be reconstructed from it.[6]
Why disagreement can matter
Some haemoglobin variants interfere with particular assay methods. Separately, conditions that shorten red-cell survival can lower A1c relative to glucose exposure even when the assay measures accurately. These are different problems: one concerns measurement interference, the other the biology behind interpretation. Discordance deserves investigation rather than choosing whichever number seems more reassuring.[3]
What to check
Keep the original result, units, test date and laboratory comments. Tell the care team about known haemoglobin variants or relevant changes such as recent blood loss or transfusion. ADA guidance recommends assessing substantial, consistent disagreement between A1c and glucose and using appropriate alternative criteria when their relationship is altered. This is a clinical assessment, not a home conversion exercise.[7]
Compare like with like
Separate three lines on the report
A report may contain A1c, estimated average glucose and a directly measured glucose result. Identify which is which before interpreting an apparent mismatch. NGSP and IFCC reporting systems can be translated through their standardized relationship, but that is different from predicting glucose exposure from A1c. A number without its analyte and unit loses essential meaning, even when a portal displays it neatly beside a coloured bar.[4]
Evidence & uncertainty
Neither timescale is universally superior for every purpose. Significant discordance can reflect assay interference or altered biology and needs context-specific assessment. This guide supplies no personal diagnosis or treatment targets.[7]
Selected-source overview · Independent review pendingPublished questions
Why can A1c and a blood-sugar reading tell different stories?
Selected-source overview · Independent review pending. Read the evidence context.
They cover different timescales: glucose measures a particular sample, while A1c reflects preceding weeks to months. A1c can also be affected by red-cell biology or assay interference. A consistent mismatch is something to investigate, not proof that one result should always overrule the other.[1][2]
Evidence behind this answer
- Interpreting A1C: principles of the A1C assay
agency condition or prevention explanation · Date not stated
Selected relevant passages of the original official page inspected · Transcript: glycated haemoglobin, red-cell lifespan, weeks-to-months and no fasting requirement - Interpreting A1C: diabetes and hemoglobin variants
agency condition or prevention explanation · Date not stated
Selected relevant passages of the original official page inspected · Transcript: assay-dependent variant interference and discordant glucose/A1c
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is HbA1c in mmol/mol the same as glucose in mmol/L?
Selected-source overview · Independent review pending. Read the evidence context.
No. The first expresses glycated haemoglobin relative to haemoglobin; the second expresses a glucose concentration. A1c percentage is another reporting system for A1c. Always keep the test name and units attached before comparing two reports or using any conversion.[4]
Evidence behind this answer
- IFCC standardization: IFCC and NGSP
laboratory standardization body explanation · Date not stated
Selected relevant passages of the original official page inspected · IFCC mmol/mol versus NGSP percent; distinct from glucose units
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is estimated average glucose another measured blood test?
Selected-source overview · Independent review pending. Read the evidence context.
Usually it is a calculation from A1c using a population-based relationship, not an extra glucose measurement. It can make the longer-term result more familiar, but variation around the relationship means it should not be read as an exact reconstruction of every person’s glucose.[6]
Evidence behind this answer
- Translating the A1C assay into estimated average glucose values
prospective measurement study · 2008
Original indexed abstract and table-description passages inspected; PMC access became intermittently browser-check blocked · Abstract and Table 2 indexed passages: 507 participants and prediction limits
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does the A1c test itself require fasting?
Selected-source overview · Independent review pending. Read the evidence context.
A1c generally does not require fasting because it reflects longer-term exposure. Other tests ordered at the same appointment may have different preparation requirements. Follow the instructions for the complete set of ordered tests rather than assuming that one test’s requirements apply to them all.[1]
Evidence behind this answer
- Interpreting A1C: principles of the A1C assay
agency condition or prevention explanation · Date not stated
Selected relevant passages of the original official page inspected · Transcript: glycated haemoglobin, red-cell lifespan, weeks-to-months and no fasting requirement
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Does having a haemoglobin variant make every A1c test unusable?
Selected-source overview · Independent review pending. Read the evidence context.
No. Interference depends on the particular variant and assay. A laboratory can sometimes use a method unaffected by that variant. Conditions that change red-cell survival are a separate interpretation problem, so changing the assay alone does not resolve every discrepancy.[2]
Evidence behind this answer
- Interpreting A1C: diabetes and hemoglobin variants
agency condition or prevention explanation · Date not stated
Selected relevant passages of the original official page inspected · Transcript: assay-dependent variant interference and discordant glucose/A1c
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
Is an A1c diagnostic limit automatically my treatment goal?
Selected-source overview · Independent review pending. Read the evidence context.
No. Diagnosing a condition and choosing a treatment goal are different clinical decisions. Guidance also specifies which assays and confirmation procedures suit diagnosis. A report’s flag should not be used to invent a personal treatment target without the care team’s assessment.[8]
Evidence behind this answer
- Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
professional guideline · 2023
Selected original full-text PMC guideline sections inspected; direct DOI retrieval returned403 · Glycated haemoglobin: diagnostic measurement, assay standardization and interpretation
This answer summarizes selected sources. An independent appraisal of the complete evidence has not been completed.
A useful long-term marker with a defined purpose
Standardization matters
Laboratory guidance distinguishes a properly standardized A1c measurement from any product simply labelled “A1c.” Methods, quality assurance and intended use matter, including whether a test is suitable for diagnosis or monitoring. This is why checking the test’s purpose is more helpful than assuming all home, office and laboratory measurements support identical decisions. The result is a measurement tool rather than a universal metabolic-health score.[8]
An average hides a pattern
Two glucose patterns can produce a similar longer-term average. A1c cannot identify the timing or frequency of individual excursions, whereas a glucose profile records a different kind of information. More recent weeks influence A1c more than earlier ones, so its change after a sustained shift need not wait for every circulating red cell to be replaced.[5]
Measurement interference and altered biology need different explanations
An assay can respond differently to a variant
A haemoglobin variant changes the molecule a method is measuring. NIDDK explains that effects differ among assays and that an unexpected difference from glucose readings should prompt consideration of interference. The presence of a variant alone does not establish that a particular result is wrong. The laboratory needs to know which variant and method are involved.[2]
A technically accurate result can still mislead
A shorter red-cell lifespan can reduce the time available for glucose attachment. Iron-deficiency anaemia and advanced kidney disease can also complicate interpretation through different mechanisms. NGSP describes these limitations separately from method-specific variant interference. It is therefore possible for a well-performing assay to produce a number that needs a different clinical interpretation; accuracy of measurement and suitability of the biological marker are not identical.[3]
References
- Interpreting A1C: principles of the A1C assay
Agency condition or prevention explanation
NIDDK / David B. Sacks · Content/publication date: not stated
Accessed: 2026-10-15 UTC · Selected relevant passages of the original official page inspected
Cited sections: Transcript: glycated haemoglobin, red-cell lifespan, weeks-to-months and no fasting requirement - Interpreting A1C: diabetes and hemoglobin variants
Agency condition or prevention explanation
NIDDK / David B. Sacks · Content/publication date: not stated
Accessed: 2026-10-15 UTC · Selected relevant passages of the original official page inspected
Cited sections: Transcript: assay-dependent variant interference and discordant glucose/A1c - Factors that interfere with HbA1c test results
Laboratory standardization body explanation
National Glycohemoglobin Standardization Program · Content/publication date: not stated
Accessed: 2026-10-15 UTC · Selected relevant passages of the original official page inspected
Cited sections: Measurement interference versus red-cell survival; iron deficiency and renal disease - IFCC standardization: IFCC and NGSP
Laboratory standardization body explanation
National Glycohemoglobin Standardization Program · Content/publication date: not stated
Accessed: 2026-10-15 UTC · Selected relevant passages of the original official page inspected
Cited sections: IFCC mmol/mol versus NGSP percent; distinct from glucose units - HbA1c and estimated average glucose
Laboratory standardization body explanation
National Glycohemoglobin Standardization Program · Content/publication date: not stated
Accessed: 2026-10-15 UTC · Selected relevant passages of the original official page inspected
Cited sections: Weighted average; recent weeks contribute more; estimated average glucose - Translating the A1C assay into estimated average glucose values
Prospective measurement study
Nathan and colleagues / A1c-Derived Average Glucose Study Group · Content/publication date: 2008
Accessed: 2026-10-15 UTC · Original indexed abstract and table-description passages inspected; PMC access became intermittently browser-check blocked
Cited sections: Abstract and Table 2 indexed passages: 507 participants and prediction limits - Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026
Professional guideline
American Diabetes Association Professional Practice Committee · Content/publication date: 2026
Accessed: 2026-10-15 UTC · Indexed original guideline recommendations inspected; direct DOI retrieval returned 403
Cited sections: Recommendations 2.3–2.4: discordance, interference and altered relationship to glycaemia - Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
Professional guideline
Sacks and colleagues · Content/publication date: 2023
Accessed: 2026-10-15 UTC · Selected original full-text PMC guideline sections inspected; direct DOI retrieval returned403
Cited sections: Glycated haemoglobin: diagnostic measurement, assay standardization and interpretation
Scope & review
- Population
- General readers interpreting medical reports; no individual diagnosis
- Exposure or intervention
- A1c versus fasting/random glucose and test interference; no personal diagnosis or glucose targets.
- Comparison
- Measurement, interpretation and clinical decisions distinguished
- Outcomes
- Understanding terms, limits and useful questions for a clinician
- Timeframe
- Test-specific; a measurement and longer-term trends are distinct
- Jurisdiction
- Selected US official guidance and international laboratory-method literature; individual laboratory and guideline context matters
Targeted source-based educational explanation. Source statements and editorial interpretation are distinguished. No exhaustive search, formal evidence grade or qualified independent clinical review completed.
Sources checked on their individual access dates. Selected sources were checked; ongoing surveillance and qualified review have separate statuses on the coverage page.
Revision history
- 2026-10-15 UTC: Added the plain-English series explanation with definitions, distinctions, practical questions and selected primary sources; qualified review remains pending.
What this article still leaves open
- Which marker best reflects glucose exposure when red-cell survival is altered?
- How should persistent discordance be evaluated with a particular assay and clinical context?
Suggest a correction
Submit a content correction to the editorial queue, or download a local note. Leave out personal medical details. Submitted text is stored privately with a browser receipt session and is visible to this browser and the editor. Clearing cookies removes access to your submission history. This is not an account or a medical service.
Your submitted corrections for this article
More in the plain-English series
Keep making sense of it.
Explore Prevention & care explanations See every explanationExplore the topic map
Browse the health domains connected to this article. The map also identifies topics whose articles remain unwritten.